American Bio Enterprises
Pharmaceutical & Health Products · Lobbying Client
C
Influence Score
45/100
Moderate Influence
$3.5M
Total Lobby Spend
5
Policy Issues
1
Lobbyists
0
Revolving Door
American Bio Enterprises reported $3.5 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 5 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
US House of Representatives
Environmental Protection Agency
Federal Communications Commission
Dept of Labor
Dept of Housing & Urban Development
Securities & Exchange Commission
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | K&L Gates LLP | MEDGOV | 1 | $151K |
| 2020 Apr-Jun | Akin Gump LLP | HCR | 1 | $214K |
| 2020 Jul-Sep | Squire Patton Boggs LLP | APP | 1 | $155K |
| 2020 Oct-Dec | Holland & Knight LLP | GOVAPPPHA | 1 | $188K |
| 2021 Jan-Mar | BGR Group LLP | GOVPHA | 1 | $136K |
| 2021 Apr-Jun | Squire Patton Boggs LLP | PHAGOVHCR+2 | 1 | $211K |
| 2021 Jul-Sep | BGR Group LLP | APPPHAHCR+2 | 1 | $168K |
| 2021 Oct-Dec | Akin Gump LLP | HCRGOVAPP+1 | 1 | $145K |